- Case report
- Open Access
- Open Peer Review
A rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus: a case report
© The Author(s). 2018
- Received: 31 July 2018
- Accepted: 7 September 2018
- Published: 6 October 2018
Pyosalpinx, which is one of the pelvic inflammatory diseases, is usually observed in young women; it is rarely found in older women. Possible causative agents are thought to be Chlamydia trachomatis and Neisseria gonorrhea in addition to some Enterobacteriaceae. On the other hand, type 2 diabetes is a disease with a lot of complications such as hyperglycemia, inflammation, and immune disorders. Therefore, patients with type 2 diabetes mellitus have an increased susceptibility to infection especially when glycemic control is poor.
We experienced a rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus. A 72-year-old Japanese woman with a 10-year history of type 2 diabetes mellitus had symptoms of diarrhea and persistent pain in left lower abdomen. She had mild tenderness to palpation in her abdomen. Inflammation markers were markedly elevated. Her abdominal computed tomography and magnetic resonance imaging on admission revealed a tumor in left side of intrapelvis and we diagnosed her as having pyosalpinx. Pathogenic bacteria were not detected. On admission, her glycemic control was relatively good; in addition, her glycated hemoglobin levels were around 6% for over 1 year. Although pathogenic bacteria were not detected, we started antibiotics therapy. Fourteen days after starting the antibiotics her laboratory data were improved. Three months later, the tumor was markedly smaller compared to that on admission.
We should keep in mind that older patients with type 2 diabetes mellitus are immunocompromised hosts and thereby they could have rare pelvic inflammatory disease such as pyosalpinx even when good glycemic control is obtained for a long period of time.
- Case report
- Type 2 diabetes mellitus
- Elderly patient
Pyosalpinx, which is one of the pelvic inflammatory diseases (PIDs), is the collection of pus in the fallopian tubes and it is a sexually transmitted infection in many cases. Therefore, pyosalpinx is usually observed in young women; it is rarely found in older women . In fact, it is thought that youth, menstruation, tobacco smoking, and having many sexual partners are the risk factors for pyosalpinx  and that the presence of pyosalpinx leads to infertility and/or the development of iliopsoas abscess. Possible causative agents are thought to be Chlamydia trachomatis and Neisseria gonorrhea in addition to some Enterobacteriaceae. In many cases, however, causative bacteria are not necessarily detected. Moreover, the clinical presentation of PID is often nonspecific and the correct diagnosis may be difficult at first based on the results of imaging studies . Although it is rare for physicians to select magnetic resonance imaging (MRI) as a first choice for diagnosis of abdominal pain, MRI is a very useful method to examine gynecological organs in older as well as young women. In addition, the continuous observation of PID with imaging studies is important to understand the clinical course.
On the other hand, type 2 diabetes mellitus (T2DM) is a disease with a lot of complications such as hyperglycemia, inflammation, and immune disorders. Therefore, patients with T2DM have an increased susceptibility to infection such as asymptomatic bacteria, urinary tract infections, and non-sexually transmitted genital infections, especially when glycemic control is poor [4, 5]. In addition, under hyperglycemic conditions, we have to be aware of the possibility of rare infection, which is seldom observed in healthy conditions.
Here we report a rare case of large pyosalpinx in an elderly patient with well-controlled T2DM. First, it is very rare that pyosalpinx is observed in older women. Second, this case report shows that various rare inflammatory diseases could be induced even when good glycemic control is obtained, suggesting that we should always pay attention to such rare inflammatory diseases in all patients with T2DM.
In this case report, we show a case of pyosalpinx in an elderly patient with well-controlled T2DM. Since her glycemic control was relatively good for over 1 year, it seemed that she was not in an immunocompromised state. However, she had a rare PID pyosalpinx while under good glycemic control. In addition, although laboratory data were within normal range even after stopping antibiotics, the tumor did not disappear completely even after 6 months. Therefore, we should think that patients with T2DM are immunocompromised hosts even when good glycemic control is obtained, and we should always pay attention to such rare inflammatory diseases in all patients with T2DM.
Pyosalpinx is a rare gynecological infection, especially in elderly women . In addition, it is thought that infectious disease is not easily induced in patients with T2DM under good glycemic control. In this case report, however, we showed a case of large pyosalpinx in an elderly patient with well-controlled T2DM. To the best of our knowledge, this is a very rare case of PID especially in elderly patients with T2DM with good glycemic control.
The annual incidence of PID in women from 15 to 39 years of age is 10 to 13 per 1000 women, with a peak incidence of approximately 20 per 1000 women at 20 to 24 years. In addition, pyosalpinx accounts for approximately 16% of all cases of PID and it is most commonly observed in women aged from 20 to 40 . Therefore, pyosalpinx is regarded as a young woman’s disease and it is rare that it is observed in older women.
On the other hand, it was reported that the presence of diabetes was associated with an increase of infectious disease [4, 5]. In fact, the presence of diabetes increases absolute risk, including urinary tract infection, genital infections, and PID by approximately 8%, although its precise mechanism remains unknown. In addition, high glucose concentration in urine increases growth of bacteria which also leads to an increase of infection in patients with T2DM. Therefore, in general, older women with T2DM and/or hyperglycemia more easily succumb to various rare infectious diseases compared to older women who do not have diabetes, although pyosalpinx is rare in older women.
Regarding PID, there is no single imaging or laboratory data with which we can correctly perform a definite diagnosis. MRI is a very useful method to examine and to diagnose gynecological organs in elderly as well as young women. DW images are particularly helpful for the diagnosis of PDI. MRI images in the pelvis show a markedly dilated fallopian tube posterior to the ovary, edema surrounding the fallopian tube, and thickened and enhanced tube wall with active inflammation . However, it is rare for physicians to select MRI as a first choice for diagnosis of abdominal pain. In this case, we performed MRI after CT examination. Once we diagnosed this patient as having pyosalpinx, we followed up with CT.
As a therapy for PID, it is recommended that antibiotics therapy is started as soon as possible for patients with a high risk factor . Therefore, although pathogenic bacteria were not detected, we started antibiotics therapy. In addition, although inflammation markers in this patient were promptly decreased with antibiotics and became within normal range (Fig. 3), the size of the pyosalpinx was not easily decreased. As shown in Fig. 1, pyosalpinx size decreased compared to that on admission but the tumor did not disappear. These findings suggest that we should know that pyosalpinx does not necessarily disappear within a short period of time even when inflammation markers are normalized and that we should continue to follow up the tumor for a long enough period by performing image inspection such as CT or MRI.
In conclusion, we should keep in mind that elderly patients with T2DM are immunocompromised hosts and thereby they could have rare PIDs such as pyosalpinx even when good glycemic control is obtained for a long period of time.
MH and TA researched data and wrote the manuscript. FK researched data and contributed to discussion. HK, KK, and NO wrote and reviewed the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980;38:880–92.View ArticleGoogle Scholar
- Simms I, Stephenson JM, Mallinson H, et al. Risk factors associated with pelvic inflammatory disease. Sex Transm Infect. 2006;82:452–7.View ArticleGoogle Scholar
- Czeyda-Pommersheim F, Kalb B, Costello J, et al. MRI in pelvic inflammatory disease: a pictorial review. Abdom Radiol (NY). 2017;42:935–50.View ArticleGoogle Scholar
- Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–3.View ArticleGoogle Scholar
- Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50:549–54.View ArticleGoogle Scholar
- Workowski KA, Bolan GA. Centers for Disease Control and Prevention.Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1–137.View ArticleGoogle Scholar